Skip to main content
Advertisement
Advertisement

CTSO

CTSO logo

Cytosorbents Corp.

3.79
USD
Sponsored
+0.06
+1.61%
Oct 09, 15:58 UTC -4
Closed
exchange

After-Market

3.89

+0.10
+2.59%

CTSO Earnings Reports

Positive Surprise Ratio

CTSO beat 21 of 43 last estimates.

49%

Next Report

Date of Next Report
Nov 03, 2026
Estimate for Q3 26 (Revenue/ EPS)
$10.11M
/
-$0.91
Implied change from Q2 26 (Revenue/ EPS)
+4.98%
/
-35.00%
Implied change from Q3 25 (Revenue/ EPS)
+6.62%
/
+1720.00%

Cytosorbents Corp. earnings per share and revenue

On Aug 06, 2026, CTSO reported earnings of -1.40 USD per share (EPS) for Q2 26, missing the estimate of -0.91 USD, resulting in a -52.51% surprise. Revenue reached 9.63 million, compared to an expected 9.53 million, with a 1.05% difference. The market reacted with a -9.68% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 4 analysts forecast an EPS of -0.91 USD, with revenue projected to reach 10.11 million USD, implying an decrease of -35.00% EPS, and increase of 4.98% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Neogen Corp
Report Date
Oct 06, 2026 For Q1 27
Estimate
-$0.07
Actual
$0.08
Surprise
+212.04%
logo
Tilray Brands, Inc. Common Stock
Report Date
Oct 08, 2026 For Q1 27
Estimate
-$0.19
Actual
-$0.32
Surprise
-64.27%
FAQ
For Q2 2026, Cytosorbents Corp. reported EPS of -$1.40, missing estimates by -52.51%, and revenue of $9.63M, 1.05% above expectations.
The stock price moved down -9.68%, changed from $0.40 before the earnings release to $0.36 the day after.
The next earning report is scheduled for Nov 03, 2026.
Based on 4 analysts, Cytosorbents Corp. is expected to report EPS of -$0.91 and revenue of $10.11M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement